MRI in treatment of adult gliomas
- John W. Henson(corresponding author),
- Paola Gaviani,
- R. Gilberto Gonzalez
- Massachusetts General Hospital Cancer Center,
- Massachusetts General Hospital
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewAbstract
<p>Diffuse astrocytomas of the adult cerebral hemispheres are unique among tumours in human beings in the extent to which their imaging features are related to histopathological characteristics and clinical behaviour. However, understanding is still restricted about the value of imaging features in the measurement of response and of progression in these tumours. The present approach used in clinical trials, which consists of an anatomical measurement of the enhancing tumour on MRI, has many problems, and might not be acceptable as a surrogate endpoint for survival in patients with glioblastoma who are enrolled in clinical trials. Dynamic imaging techniques, such as capillary permeability mapping, are being used in studies of new drugs that target specific molecular features of gliomas; however, the validity of these techniques has not been elucidated. Diffusion imaging can be valuable for fibre-tract mapping to assist surgical planning and might become useful in measuring early response to treatment in densely cellular tumours. Functional imaging techniques can be used to localise motor, sensory, and language-control areas before surgery. Intraoperative MRI has produced improvements in the extent of tumour resection, and molecular imaging is another technique on the horizon, which could come to have a role in clinical trials in the near future. Thus, as a rapidly expanding sphere of investigation, brain-tumour imaging is producing great excitement. The aim of these new techniques is to aid the identification of more effective treatments.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 167-175 (9 pages)Journal (Volume, Issue Number)
The Lancet Oncology (Volume 6, Issue 3)Publication milestones
- Published - 03/01/2005
Publication status
Published - 03/01/2005
ISSN
1470-2045Publication IDs
- Scopus: 14544298764
- PubMed: 15737833
Publication metrics
Metrics
SciVal
citations
88
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
2.01
SciVal
Author count
3
SciVal
Paper percentile
93
SciVal
Top percentile
10
PlumX, opens in new tab
Citation count
106
Captures
99
